Inhibikase Therapeutics, Inc.IKTNASDAQ
Loading
Total Costs & Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+41.4%
5Y CAGR+71.1%
Year-over-Year Change
Total of all costs and expenses
3Y CAGR
+41.4%/yr
vs +71.3%/yr prior
5Y CAGR
+71.1%/yr
Recent deceleration
Acceleration
-29.8pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
14.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $51.62M | +80.6% |
| 2024 | $28.59M | +40.5% |
| 2023 | $20.35M | +11.5% |
| 2022 | $18.25M | +2.2% |
| 2021 | $17.87M | +408.0% |
| 2020 | $3.52M | -48.4% |
| 2019 | $6.82M | +221.4% |
| 2018 | $2.12M | -13.9% |
| 2017 | $2.47M | +56.0% |
| 2016 | $1.58M | - |